Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 136.67
-0.51 %
$ 21.7 B
Market Cap
-13.71
P/E
ILMN - COST OF REVENUE
Cost of Revenue ILMN - Illumina, Inc.
1.76 B
LAST VALUE
13.26%
2 YEAR CAGR
11.25%
5 YEAR CAGR
13.20%
10 YEAR CAGR